Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits
- 11 March 2024
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 96, 102269
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation
This publication has 112 references indexed in Scilit:
- Mitophagy regulation in aging and neurodegenerative diseaseBiophysical Reviews, 2023
- The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s DiseaseMolecular Neurobiology, 2020
- The therapeutic and nutraceutical potential of agmatine, and its enhanced production using Aspergillus oryzaeAmino Acids, 2019
- Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and ReceptorsNeurochemical Research, 2019
- The neuroprotective effect of agmatine against amyloid β-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt/GSK-3β, and TNF-αMolecular Biology Reports, 2018
- Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer's disease: A narrative reviewInternational Journal of Geriatric Psychiatry, 2018
- Agmatine protects rat liver from nicotine-induced hepatic damage via antioxidative, antiapoptotic, and antifibrotic pathwaysNaunyn-Schmiedeberg's Archives of Pharmacology, 2016
- Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in MiceMolecular Neurobiology, 2015
- A practical algorithm for managing Alzheimer's disease: what, when, and why?Annals of Clinical and Translational Neurology, 2015
- Mild Cognitive Impairment Represents Early-Stage Alzheimer DiseaseArchives of Neurology, 2001